15 — GLP 105: Introduction to FDA GLP Bioresearch Monitoring Compliance Program (One-day, In person and virtual)
Friday, 8 April 2022, 8:00 AM - 5:00 PM, PDT
Registration Rates
- By 7 March 2022: Member $495, Non-member $615, University Members $375,* Student/Outreach Members $255
- After 7 March 2022: Member $545, Non-member $665, University Members $425,* Student/Outreach Members $255
RQAP re-registration units: 8.00 GLP or non-GCP
*Note: Participants must attend 100% of the training course to receive a certificate of attendance documenting RQAP re-registration units.
Presenters
Barb Munch, Eric Pittman (FDA), Lori Wright, RQAP-GLP
Description
This course will review the FDA Compliance Program for Bioresearch Monitoring of the Good Laboratory Practice for Nonclinical Laboratory Studies (GLP) regulations (7348.808). FDA implemented this program of regular inspections and data audits to monitor laboratory compliance with the GLP regulations. The Compliance Program directs the FDA Investigators how to conduct their GLP inspections of firms.
Objectives
At the end of the course, the participants shall be able to:
- Understand how the FDA uses the Compliance Program to perform inspections
- Apply the GLP Compliance Program information to build compliant processes
- Manage an FDA Inspection and respond to a 483
- Understand what records to provide the FDA Investigator/s during an inspection
- Interpret selected warning letter findings based on understanding the Compliance Program and GLP regulations
Target Audience
FDA GLP QA Auditors and Managers, from beginners to experienced, as well as Study Directors, Principal Investigators, and Testing Facility Management
Agenda
- The FDA GLP Compliance Program
- Compliance Program Content
- Managing an Inspection and Responses
- Remote Regulatory Assessments to On-site Inspections
- Other Useful FDA Documents
- Changes between Compliance Program versions
- Along with Inspection Real Life Examples & Lessons Learned and Discussion Topics